Drug intelligence / Profile preview

Borraginol A

Development stage
Unknown
Lead developer
Amato Pharmaceutical Products
Modality
Small Molecules
Administration
Rectal, Topical
01

Overview

Borraginol A is a Category 2 over-the-counter (OTC) combination medication developed by Amato Pharmaceutical Products for the relief of symptoms associated with hemorrhoids and anal fissures, including pain, bleeding, swelling, and itching. It is formulated with four active ingredients: prednisolone acetate (a mild corticosteroid that suppresses inflammation, bleeding, and swelling), lidocaine (a local anesthetic that relieves pain and itching), allantoin (which promotes wound healing and tissue repair), and tocopheryl acetate (vitamin E acetate, which improves peripheral blood circulation and relieves congestion). Borraginol A is available in multiple rectal formulations, including suppositories, ointments, and prefilled disposable applicators.

Brand names
Borraginol ABorraginol A Injection OintmentBorraginol A OintmentBorraginol A Ointment in Prefilled Disposable ApplicatorBorraginol A Suppositories
Other names
allantoin + lidocaine + prednisolone acetate + tocopheryl acetateallantoin + lidocaine + prednisolone acetate + vitamin E acetate
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Borraginol A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Borraginol A.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call